Aytac Emrah, Gürkaş Erdem, Akpinar Cetin Kursad, Saleem Muhammad A, Qureshi Adnan I
Ankara Numune Training and Research Hospital, Neurology Clinic, Ankara, Turkey.
Zeenat Qureshi Stroke Institute, St Cloud, Minnesota, USA.
J Neurointerv Surg. 2017 Oct;9(10):933-936. doi: 10.1136/neurintsurg-2016-012661. Epub 2016 Oct 3.
To determine the relative effectiveness of proximal and distal protection in prevention of cerebral ischemic events during carotid artery stent (CAS) placement using diffusion-weighted MRI (DW-MRI).
We analyzed data from patients who had undergone DW-MRI before and within 24 hours of CAS for symptomatic internal carotid artery (ICA) stenosis (with last ischemic events within 3 months). The study was performed prospectively; patients were not randomized, and were treated either with a proximal balloon occlusion system (Mo.Ma; Invatec, Roncadelle, Italy) or filter-type distal protection device (Spider device; ev3, Plymouth, Minnesota, USA).
Of the 45 patients (mean age±SD: 66.9±9.8 years; 73.3% were men) who underwent CAS, 19 had proximal protection and 26 distal protection. New ischemic lesions were detected in 26/45 patients on DW-MRI scans obtained within 24 hours after CAS. The proportion of patients with new lesions on DW-MRI at 24 hours was not different between the two groups (47.4% vs 65.4% for proximal and distal protection, respectively). The mean number of new ischemic lesions on post-CAS DW-MRI was non-significantly higher in patients who underwent CAS with distal protection (2.80±3.54 for proximal protection vs 4.96±5.11 for distal protection; p=0.12). The proportion of patients with new lesions >1 cm did not differ between the two groups (5.3% for proximal protection vs 11.5% for distal protection; p=0.62). There was no difference in the rates of ischemic stroke between patients who underwent CAS treatment using proximal and distal protection (5.3% vs 7.7%; p=1.000).
We found a relatively high rate of new ischemic lesions in patients undergoing CAS with cerebral protection. There was no difference in the proportion of patients with new lesions between patients treated using distal protection and those treated using proximal protection.
使用弥散加权磁共振成像(DW-MRI)确定在颈动脉支架置入术(CAS)过程中近端和远端保护在预防脑缺血事件方面的相对有效性。
我们分析了有症状的颈内动脉(ICA)狭窄(在3个月内有最后一次缺血事件)患者在CAS术前及术后24小时内接受DW-MRI检查的数据。该研究为前瞻性研究;患者未随机分组,分别接受近端球囊闭塞系统(Mo.Ma;意大利因瓦特克公司,龙卡代莱)或滤网式远端保护装置(Spider装置;美国ev3公司,明尼苏达州普利茅斯)治疗。
在接受CAS的45例患者(平均年龄±标准差:66.9±9.8岁;73.3%为男性)中,19例采用近端保护,26例采用远端保护。在CAS术后24小时内进行的DW-MRI扫描中,26/45例患者检测到新的缺血性病变。两组在术后24小时DW-MRI上出现新病变的患者比例无差异(近端保护组和远端保护组分别为47.4%和65.4%)。接受远端保护的CAS患者术后DW-MRI上新发缺血性病变的平均数量略高于近端保护组(近端保护组为2.80±3.54,远端保护组为4.96±5.11;p=0.12)。新病变>1cm的患者比例在两组间无差异(近端保护组为5.3%,远端保护组为11.5%;p=0.62)。采用近端和远端保护进行CAS治疗的患者缺血性卒中发生率无差异(5.3%对7.7%;p=1.000)。
我们发现接受脑保护的CAS患者中新发缺血性病变的发生率相对较高。采用远端保护治疗的患者和采用近端保护治疗的患者出现新病变的比例无差异。